{
    "Trade/Device Name(s)": [
        "ImmunoCAP Specific IgE",
        "ImmunoCAP Allergen d202",
        "Allergen component rDer p 1",
        "House dust mite"
    ],
    "Submitter Information": "Phadia US Inc.",
    "510(k) Number": "K150597",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101251"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHB"
    ],
    "Summary Letter Date": "February 1, 2016",
    "Summary Letter Received Date": "February 2, 2016",
    "Submission Date": "February 1, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.5750"
    ],
    "Regulation Name(s)": [
        "Radioallergosorbent (RAST) immunological test system"
    ],
    "Analyte Class(es)": [
        "allergy",
        "immunology"
    ],
    "Analyte(s)": [
        "Allergen specific IgE",
        "rDer p 1 (House dust mite)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Phadia 100",
        "Phadia 250",
        "Phadia 1000",
        "Phadia 2500",
        "Phadia 5000"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Fluorescence measurement"
    ],
    "Methodologies": [
        "Automated in vitro quantitative assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ImmunoCAP Specific IgE assay measuring allergen specific IgE to rDer p 1 (House dust mite) using recombinant protein on Phadia instruments",
    "Indications for Use Summary": "In vitro quantitative assay for measurement of allergen specific IgE in human serum or plasma as an aid in diagnosing IgE mediated allergic disorders in conjunction with clinical findings",
    "fda_folder": "Immunology"
}